Rapid killing of bacteria by a new type of photosensitizer
- 664 Downloads
Photodynamic antimicrobial chemotherapy (PACT) uses non-traditional mechanisms (free radicals) and is a highly advocated method with promise of inactivating drug-resistance bacteria for local infections. However, there is no related drug used in clinical practice yet. Therefore, new photosensitizers for PACT are under active development. Here, we report the synthesis of a series of photosensitizers with variable positive charges (ZnPc(TAP)4 n+, n = 0, 4, 8, 12) and their inactivation against Gram-positive (Staphylococcus aureus) and Gram-negative (Escherichia coli) bacteria. The binding kinetics of ZnPc(TAP)4 n+ to bacteria were measured by flow cytometer. Reactive oxygen species (ROS) generation mechanism of the photosensitizers was studied. The toxicity of these compounds to human blood cells was also evaluated. These compounds showed negligible toxicity against human erythocytes but potent bactericidal effects. The compound with 8 positive charges, ZnPc(TAP)4 8+, turned out to have the strongest antibacterial effect among this series of compounds, giving IC50 value of 59 nM at a light dosage of 5 J/cm2 toward E. coli. For a multi-resistant E. coli strain, ZnPc(TAP)4 8+ decreased the bacteria load by 1000-fold at a concentration of 1 μM. Interestingly, ZnPc(TAP)4 12+, instead of ZnPc(TAP)4 8+, exhibited the highest amount of binding to bacteria. Flow cytometry studies showed that all PSs have fast binding onto bacteria, reaching saturated binding within 5 min. Mechanistically, ZnPc(TAP)4 12+ generated ROS primarily via Type I mechanism, while ZnPc(TAP)4 4+ or ZnPc(TAP)4 8+ created ROS by both type I and type II mechanisms. ZnPc(TAP)4 n+ are highly potent, rapid-acting and non-toxic photosensitizers capable of inactivating bacteria.
KeywordsPhotodynamic antimicrobial chemotherapy (PACT) Mechanistic study ROS measurement Phthalocyanine Photosensitizer
We thank The Second Municipal Hospital of Fuzhou for providing us the strain of multi-resistant E. coli. This work was supported by grants from National Natural Science Foundation of China (81171634), Natural Science Foundation of Fujian Province (2013J01066).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
This work is supported by grants from Natural Science Foundation of China (31,370,737, 31,400,637, 31,570,745, 31,670,739, 81,572,944, and U1405229), and the CAS/SAFEA International Partnership Program for Creative Research Teams.
- Alves E, Costa L, Carvalho CM, Tome JP, Faustino MA, Neves MG, Tome AC, Cavaleiro JA, Cunha A, Almeida A (2009) Charge effect on the photoinactivation of Gram-negative and Gram-positive bacteria by cationic meso-substituted porphyrins. BMC Microbiol 9:70. doi: 10.1186/1471-2180-9-70 CrossRefPubMedPubMedCentralGoogle Scholar
- Banfi S, Caruso E, Buccafurni L, Battini V, Zazzaron S, Barbieri P, Orlandi V (2006) Antibacterial activity of tetraaryl-porphyrin photosensitizers: an in vitro study on Gram negative and Gram positive bacteria. J Photochem Photobiol B 85(1):28–38. doi: 10.1016/j.jphotobiol.2006.04.003 CrossRefPubMedGoogle Scholar
- Dwyer DJ, Belenky PA, Yang JH (2014) Antibiotics induce redox-related physiological alterations as part of their lethality. 111(20):E2100–9 doi: 10.1073/pnas.1401876111
- Eichner A, Gonzales FP, Felgentrager A, Regensburger J, Holzmann T, Schneider-Brachert W, Baumler W, Maisch T (2013) Dirty hands: photodynamic killing of human pathogens like EHEC, MRSA and Candida within seconds. Photochem Photobiol Sci 12(1):135–147. doi: 10.1039/c2pp25164g CrossRefPubMedGoogle Scholar
- Hemmerling A, Harrison W, Schroeder A, Park J, Korn A, Shiboski S, Foster-Rosales A, Cohen CR (2010) Phase 2a study assessing colonization efficiency, safety, and acceptability of Lactobacillus crispatus CTV-05 in women with bacterial vaginosis. Sex Transm Dis 37(12):745–750. doi: 10.1097/Olq.0b013e3181e50026 CrossRefPubMedGoogle Scholar
- Karsi A, Lawrence ML (2007) Broad host range fluorescence and bioluminescence expression vectors for Gram-negative bacteria. Plasmid 57(3):286–295. doi: 10.1016/j.plasmid.2006.11.002
- Kiesslich T, Gollmer A, Maisch T, Berneburg M, Plaetzer K (2013) A comprehensive tutorial on in vitro characterization of new photosensitizers for photodynamic antitumor therapy and photodynamic inactivation of microorganisms. Biomed Res Int 2013:840417. doi: 10.1155/2013/840417 CrossRefPubMedPubMedCentralGoogle Scholar
- Mikula P, Kalhotka L, Jancula D, Zezulka S, Korinkova R, Cerny J, Marsalek B, Toman P (2014) Evaluation of antibacterial properties of novel phthalocyanines against Escherichia coli–comparison of analytical methods. J Photochem Photobiol B 138:230–239. doi: 10.1016/j.jphotobiol.2014.04.014 CrossRefPubMedGoogle Scholar
- Morley S, Griffiths J, Philips G, Moseley H, O'Grady C, Mellish K, Lankester CL, Faris B, Young RJ, Brown SB, Rhodes LE (2013) Phase IIa randomized, placebo-controlled study of antimicrobial photodynamic therapy in bacterially colonized, chronic leg ulcers and diabetic foot ulcers: a new approach to antimicrobial therapy. The British journal of dermatology 168(3):617–624. doi: 10.1111/bjd.12098 CrossRefPubMedGoogle Scholar
- Smirnova ZS, Oborotova NA, Makarova OA, Orlova OL, Polozkova AP, Kubasova IY, Luk'yanets EA, Meerovich GA, Zimakova NI, Kuz'min SG, Vorozhtsov GN, Baryshnikov AY (2005) Efficiency and pharmacokinetics of photosense: a new liposomal photosensitizer formulation based on aluminum sulfophthalocyanine. Pharm Chem J 39(7):341–344. doi: 10.1007/s11094-005-0150-8 CrossRefGoogle Scholar
- World Health Assembly (2015) Sixty-eighth World Health Assembly. Publisher. http://www.who.int/mediacentre/news/releases/2015/wha-25-may-2015/en/